Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Alpha Emitter Market Anticipated to Reach $2,649.1 Million, Globally, by 2030 at 10.3% CAGR: Coherent Market Insights (CMI)

Published

on

Burlingame, July 25, 2023 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global alpha emitter market is estimated to be valued at US$ 1,311.0 million in 2023 and is expected to exhibit a CAGR of 10.3% during the forecast period (2023-2030).

Analysts’ Views on Global Alpha Emitter Market:

Increasing in the adoption of growth strategies such as agreements to strengthen its product portfolio is expected to drive the growth of the market over the forecast period. For instance, in January 2022, IONETIX Corporation announced that it had signed a supply agreement for the therapeutic radioisotope astatine-211 (211At) with Precision Molecular, Inc. (PMI), a clinical-stage company, developing targeted radiopharmaceuticals and theranostics for patients with cancer.

Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/5534   

Key Trends and Analysis of the Global Alpha Emitter Market:

Increasing research and development

Increasing research and development by key market players for the treatment of patients with neuroendocrine tumors is expected to propel the segment growth over the forecast period. For instance,

Increase in adoption of organic growth strategies such as facility expansion

An increase in inorganic growth strategies such as facility adopted by key market players in is expected to drive the market growth. For instance, in March 2022, Telix Pharmaceuticals Limited., announced the opening of its radiopharmaceutical production facility in Brussels South in the Wallonia region of Belgium. The new facility will serve as the primary European manufacturing site for Telix’s products, aligning with the company’s strategic objective of maintaining control and reliability of its supply chain, as well as cost control. It will also be an integral hub for Telix’s R&D activities, specifically in for the scale-up of radioisotope production.

Global Alpha Emitter Market Cross Sectional Analysis:

In type of radionuclide segment, Radium (Ra-223) held a dominant segment in North America region due to the increasing approval of radioligand therapy by regulatory bodies for treatment of prostate cancer is expected to propel the market growth over the forecast period. According to article published in August 2022, by Radiation journal, a researcher from Kindai University, Japan, has investigated into the optimal Strategy of Radium-223 Therapy for Metastatic Castration-Resistant Prostate Cancer and concluded that early administration of Ra-223 was significantly associated with improved OS and that it might be beneficial to administer Ra-223 before novel hormonal or anticancer agents.

Alpha Emitter Market Report Coverage

Report Coverage Details
Base Year: 2022   Market Size in 2023: US$ 1,331.0 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 to 2030
Forecast Period 2023 to 2030 CAGR: 10.35%   2030 Value Projection: US$ 2,649.1 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Type of Radionuclide: Radium (Ra-223), Actinium (Ac-225), Lead (Pb-212), Astatine-211, Bismuth-213, Others
  • By Source : Natural Sources (Uranium-238, Radium-226), Artificially Produced Sources (Plutonium, Americium, Curium, Californium)
  • By Application: Bone Metastases, Prostate Cancer, Neuroendocrine Tumors, Ovarian Cancer, Others
  • By End User: Hospitals, Specialty Clinics, Diagnostic Centers, Others
Companies covered: Actinium Pharmaceutical Inc., Alpha Tau Medical Ltd, Bayer AG, Bracco, Cardinal Health, Eckert & Ziegle, Fusion Pharmaceuticals, IBA Worldwide, NorthStar Medical Radioisotopes (NMR), Orano Group, Viewpoint Molecular Targeting, RadioMedix, Telix Pharmaceuticals Limited., TerraPower, LLC, NIOWAVE Inc. and IONETIX Corporation.
Growth Drivers:
  • Increasing  prevalence of cancer worldwide
  • Increasing research and development activities
Restraints & Challenges:
  • Drawbacks associated with the targeted alpha particle therapy

Global Alpha Emitter Market: Key Developments

On December, 2020, Telix Pharmaceuticals Limited., announced that it has been granted Human Research Ethics Committees (HREC) approval and received CTN clearance by the TGA to commence Phase I study of the company’s next generation prostate cancer therapy product TLX592, in patients with advanced prostate cancer. TLX592 has been developed using Telix’s proprietary RADmAb engineered antibody technology. Like the company’s existing TLX591 antibody development program, TLX592 targets prostate specific membrane antigen (PSMA) – a target that is almost ubiquitously expressed by prostate cancer cells. TLX592 has been engineered to clear far more rapidly from a patient’s circulation, making it suitable for use as a targeting agent for 225Ac (actinium-225)

Request Customization of this Report @ https://www.coherentmarketinsights.com/insight/request-customization/5534

In January 2022, RadioMedix, and Orano Med, a biotechnology company, announced the initiation of the Phase II clinical trial of AlphaMedix with the treatment of the first patient on December 21, 2021. This trial will evaluate the safety and effectiveness of 212Pb-DOTAMTATE (AlphaMedix) in Peptide Receptor Radionuclide Therapy (PRRT) of naive patients with somatostatin receptor-expressing neuroendocrine tumors (NET).

In November 2021, Viewpoint Molecular Targeting announced that it had entered into a Memorandum of Understanding (MoU) agreement with the National Nuclear Laboratory (NNL), a U.K. government owned and operated nuclear services technology provider that covers whole nuclear fuel cycle and to clinicians, in the U.K., and Europe, using Viewpoint’s proprietary isotope generator named VMT-GEN.

On February 6, 2023, Viewpoint Molecular Targeting announced merger with Isoray, Inc., a medical technology company. Both companies will focus on the advancement of cancer treatments by using radiation, radiopharmaceuticals, and imaging technologies so that precision, targeted medical doses are delivered directly to cancer patient tumor sites.

Key Market Takeaways:

The global alpha emitter market is expected to exhibit a CAGR of 10.3% during the forecast period, owing to increase in the adoption of growth strategies such as mergers, in order to strengthen its product portfolio. For instance, on February 6, 2023, Viewpoint Molecular Targeting announced merger with Isoray, Inc., a medical technology company. Both companies will focus on the advancement of cancer treatments by using radiation, radiopharmaceuticals, and imaging technologies so that precision, targeted medical doses are delivered directly to cancer patient tumor sites.

Among end user, the hospital segment is estimated to hold a dominant position in the global alpha emitter over the forecast period due to increasing in the number of hospitals and increasing number of patient admitted per year in hospitals are expected to drive the growth of the segment over the forecast period. For instance, according to a factsheet published by the American Hospital Association in October 2022, there were more than 6,093 hospitals in the U.S. in 2020 and total admissions in all the U.S. hospitals was more than 33,356,853.

On the basis of region, North America is estimated to account for the largest market share in the global alpha emitter market over the forecast period due to the increasing product approvals by the regulatory authorities. For instance, in November 2022, Novartis, a pharmaceutical corporation, announced that the U.S. Food and Drug Administration (FDA) had approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for the treatment of adult patients with a type of advanced cancer called prostate-specific membrane antigen–positive metastatic castration-resistant prostate cancer (PSMA-positive mCRPC) which spreads to other parts of the body (metastatic). Such patients are selected to the trials who have already been treated with other anticancer treatments (androgen receptor pathway inhibition and taxane-based chemotherapy) but the treatment was not effective.

Competitive Landscape:

Key players operating in the global alpha emitter market include Actinium Pharmaceutical Inc., Alpha Tau Medical Ltd, Bayer AG, Bracco, Cardinal Health, Eckert & Ziegle, Fusion Pharmaceuticals, IBA Worldwide, NorthStar Medical Radioisotopes (NMR), Orano Group, Viewpoint Molecular Targeting, RadioMedix, Telix Pharmaceuticals Limited., TerraPower, LLC, NIOWAVE Inc. and IONETIX Corporation.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/5534

Market Segmentation:

Global Alpha Emitter Market, By Type of Radionuclide:

  • Radium (Ra-223)
  • Actinium (Ac-225)
  • Lead (Pb-212)
  • Astatine-211
  • Bismuth-213
  • Others

Global Alpha Emitter Market, By Source:

  • Natural Sources
    • Uranium-238
    • Radium-226
  • Artificially Produced Sources
    • Plutonium
    • Americium
    • Curium
    • Californium

Global Alpha Emitter Market, By Application:

  • Bone Metastases
  • Prostate Cancer
  • Neuroendocrine Tumors
  • Ovarian Cancer
  • Others

Global Alpha Emitter Market, By End User:

  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
  • Others

Global Alpha Emitter Market, By Region:

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa

Related Market Intelligence Reports:

Glaucoma Eye Drops Market, by Drug Type (Prostaglandin analogs, Beta blockers, Alpha agonists, Carbonic Anhydrase Inhibitors (CAIs), Combined Medications and Others (rho-kinase inhibitor, Cholinergic agonist), by Disease Indication (Angle-closure Glaucoma and Open-angle Glaucoma), By Distribution Channel (Hospital Pharmacy Retail Pharmacy and Online Pharmacy), by Composition (Preservative Free, BAK-Based and Non BAK-Based Preservatives), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), – Size, Share, Outlook, and Opportunity Analysis, 2023 – 2030

Rosacea Treatment Market, By Drug VClass (Antibiotics, Alpha agonists, Retinoids, Corticosteroids, Immunosuppressants, Other drug classes), By Route of Administration (Topical, Oral), By Type (Erythematotelangiectatic rosacea, Papulopustular rosacea, Ocular rosacea, Phymatous rosacea), By End-user (Hospitals, Clinics, Retail pharmacies, Online pharmacies), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 – 2030

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Follow Us: LinkedInTwitter


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Northern Data Group’s Peak Mining announces new partnership for 28MW of mining, powered by 100% renewable energy

Published

on

northern-data-group’s-peak-mining-announces-new-partnership-for-28mw-of-mining,-powered-by-100%-renewable-energy

28MW of miners delivering 1.3 EH/s, strategically located in Paraguay2,860 units of MicroBT’s M63-series liquid-cooled WhatsMiners to be installedPower rate of sub $0.04/kWh, generated by 100% renewable hydropowerFRANKFURT, Germany , May 10, 2024 /PRNewswire/ — Northern Data Group’s Peak Mining today announces a new partnership with Penguin Infrastructure Holding (“Penguin”) for 28MW of mining capacity. This project represents a significant next step in Northern Data Group’s geographical expansion and enables Peak Mining to increase its hashrate, powered by 100% renewable energy.

The hardware will be energized in H2 2024 and marks Peak Mining’s first step into South America. 2,860 units of MicroBT’s M63-series liquid-cooled WhatsMiners will be installed at the site. The hardware will generate 1.3 EH/s, contributing to Peak Mining’s planned growth to 7.9 EH/s this year.
The site in Paraguay is 100% powered by renewable hydropower harnessed from the 14 GW Itaipu Dam, it is the world’s third-largest hydroelectric dam. The site will therefore benefit from the availability of clean energy.
This expansion into South America follows Peak Mining’s recent purchase of a 300MW mining data center site in Corpus Christi, Texas, which will power around 4.2 EH/s of MicroBT’s miners as well as the construction of a 30MW facility in Grand Forks, North Dakota, which will support approximately 1.1 EH/s of the miners.
This selection of sites underscores Northern Data Group’s commitment to meet the demands of the industry as efficiently as possible. Throughout 2024, Northern Data Group will be rapidly expanding its HPC footprint. 
Aroosh Thillainathan, Northern Data Group’s Chief Executive Officer, commented:
“This partnership is significant to Northern Data Group as we continue to execute on our investment strategy and solidify our position within the global High Performance Computing market, and I’m especially pleased to be working with Penguin, given the team’s impressive sustainability standards at this site. It is Peak Mining’s first expansion into South America and is another milestone for the company as it continues to scale its international Bitcoin mining capabilities.”
Niek Beudeker, Managing Director, Peak Mining, commented:
“I’m pleased to partner with Penguin to expand our mining capacity to Paraguay. The Penguin team has done a tremendous job in constructing the site and building a strong local team. This agreement, structured as a partnership, will allow for better alignment of both parties than with a standard hosting arrangement. The partnership demonstrates our commitment to leveraging 100% clean energy to meet growing industry demand, efficiently”.
Björn Schmidtke, CEO at Penguin Group, commented:
“This strategic alliance with Northern Data Group strengthens our position as a leader in hosting next-generation High Performance Computing and also allows us to strengthen our capabilities and expand our offerings in cutting-edge areas such as AI compute. We are committed to advancing in this constantly accelerating world, which demands more high-quality services to keep evolving.”
About Peak Mining
Peak Mining, part of the Northern Data Group, is powering the future of the Bitcoin network. We deliver industry-leading operating and energy efficiency in Bitcoin mining through the latest hardware alongside innovative technology and HPC infrastructure. With our heritage dating back to 2013, we’ve been innovating for over a decade and have been at the forefront of the industry ever since. Our high-quality infrastructure is purpose-built to secure the Bitcoin network, and we’re driven to continuously find new efficiencies driving value for our investors. We’re delivering long term value in more responsible ways.
About Penguin
Penguin Group is at the forefront of HPC and cloud services powered by fully renewable hydro power in South America. Its core value is the mission to Transform Energy into Human Potential. This mission is achieved through Penguin Academy, a revolutionary education concept where students ‘learn by doing’ and has already trained thousands of young people to become the next generation of tech talent. Penguin aims to transform Paraguay into the Technological Hub of South America and expand their concept and mission globally.
About Northern Data Group
Northern Data Group (ETR: NB2) is a leading provider of High Performance Computing (HPC) solutions, utilizing GPU- and ASIC-technology. Our flexible compute power fuels innovation in our three core business platforms: Taiga Cloud, Ardent Data Centers, and Peak Mining. Through our HPC solutions, we pioneer ambitious computing innovation that drives progress in the AI, ML and Generative AI industries. Our close collaboration with industry-leading manufacturers including Gigabyte, AMD, and NVIDIA is fundamental to the acceleration of innovation across sectors including life sciences, financial services, and energy.  

View original content:https://www.prnewswire.co.uk/news-releases/northern-data-groups-peak-mining-announces-new-partnership-for-28mw-of-mining-powered-by-100-renewable-energy-302141597.html

Continue Reading

Artificial Intelligence

Sanad Announces Strategic Sale Transaction with CFM Materials, Further Fostering Aviation Industry Collaborations

Published

on

sanad-announces-strategic-sale-transaction-with-cfm-materials,-further-fostering-aviation-industry-collaborations

Sanad’s sale of two CFM56-7B engines to CFM Materials highlights its ongoing commitment to strengthening industry partnershipsBy partnering with leading aftermarket specialists, Sanad reaffirms its commitment to proactive portfolio management and strategic capital allocationHONG KONG, May 10, 2024 /PRNewswire/ — Sanad, the global aerospace engineering and leasing solutions leader, wholly owned by Abu Dhabi’s sovereign investor Mubadala Investment Company PJSC (Mubadala), unveiled a strategic transaction between Sanad and CFM Materials, the world’s largest provider of used serviceable components for CFM International engines, during the International Society of Transport Aircraft Trading (ISTAT) Asia in Hong Kong.

The sale of two CFM56-7B* engines to CFM Materials underscores Sanad’s strategic shift and proactive approach to strengthening its market position in the aviation industry. Through strategic partnerships with leading aftermarket specialists, Sanad not only reaffirms its commitment but also solidifies its vital role as a key player in shaping the aviation landscape.
This strategic agreement marks a pivotal milestone for the Sanad Leasing division’s ongoing strategy, which was initiated last year with a renewed focus on monetizing existing assets and leveraging the Sanad Leasing division to empower the Sanad MRO division. The primary goal of this strategy is to drive and bolster the growth of the MRO division of Sanad.
Kashish Kohli, Group Chief Financial Officer and SVP Leasing Division at Sanad, said: “We are pleased to announce the successful sale of two CFM56 engines to CFM Materials. This transaction reaffirms our commitment to optimizing our portfolio collaborating with industry leaders like CFM Materials. We are eager to explore further synergies between our respective organizations to explore further avenues of cooperation in the future.”
This collaboration presents new opportunities for CFM Materials to support MRO networks, airlines, lessors, manufacturers, and other service providers worldwide. Adding two CFM56-7B engines to CFM Materials portfolio enables them to meet the increasing demand from customers.
Rudy Bryce, President and CEO of CFM Materials, commented: “This agreement with Sanad strengthens our commitment to support our customers by expanding our lease pool and bolstering our position as a reliable partner to engine owners, operators and CFM56 engine shops around the world.”
With over 35 years of operational excellence and trusted partnerships with over 30 customers across six continents, including world-leading international airlines and global OEMs, Sanad remains at the forefront of aerospace engineering and leasing solutions. The Sanad Leasing division, a key pillar of Sanad’s comprehensive offerings, is committed to providing integrated solutions that address the growth requirements of its partners. Currently, the Sanad Leasing division boasts a substantial portfolio exceeding USD 700 million in assets, showcasing its robust capabilities and dedication to supporting the aviation industry’s evolving needs.
About Sanad
Sanad Group (Sanad) is a global aerospace engineering and leasing solutions leader in Abu Dhabi wholly owned by Mubadala Investment Company PJSC. With more than 35 years of operational experience, Sanad supports leaders in commercial aviation with world-class maintenance, repair, and overhaul (MRO) services and financing solutions. 
Visit us at www.sanad.ae. Follow us on Instagram, Facebook and LinkedIn @TheSanadGroup.
About CFM Materials
Based near DFW Airport, Texas, CFM Materials, a joint venture of GE Aerospace and Safran Aircraft Engines, is the world’s largest provider of used serviceable components for CFM International engines that power the Airbus A320 and Boeing 737 commercial jetliners, as well as the Boeing KC-135R aerial tanker operated by the U.S. Air Force.
In addition to its core operation, the company also sells surplus inventories for CFM International and provides inventory for its parent companies’ MRO (maintenance, repair and overhaul) network around the world. CFM Materials has a global presence with warehouse facilities located near DFW Airport, Texas, Amsterdam, Hamburg, and Singapore; along with sales offices in Singapore and Cardiff, Wales. www.cfmmaterials.com 
*CFM56 engines are a product of CFM International, a 50/50 joint company between GE Aerospace and Safran Aircraft Engines.
Photo: https://mma.prnewswire.com/media/2408079/Sanad_CFM.jpg
For more information, please contact: Raneem Khatib Edelman [email protected] +971 50 204 9791

View original content:https://www.prnewswire.co.uk/news-releases/sanad-announces-strategic-sale-transaction-with-cfm-materials-further-fostering-aviation-industry-collaborations-302142116.html

Continue Reading

Artificial Intelligence

CoreWeave Invests £1 Billion in UK; Opens New European Headquarters and Data Centres in London to Bring Cloud Infrastructure to Power the AI Revolution

Published

on

coreweave-invests-1-billion-in-uk;-opens-new-european-headquarters-and-data-centres-in-london-to-bring-cloud-infrastructure-to-power-the-ai-revolution

LONDON, May 10, 2024 /PRNewswire/ — CoreWeave, the leading specialized cloud provider for AI, today announced that it has opened an office in London as its European headquarters as part of a broader expansion into the continent. The new UK expansion represents a £1 billion investment to bolster the country’s AI potential, and will create job opportunities across engineering, operations, finance and go-to-market. CoreWeave plans to open two UK data centres in 2024 with further expansion planned in 2025.

“We are seeing unprecedented demand for AI infrastructure and London is an important AI hub that we are investing in. Expanding our physical footprint in the UK is an important milestone in the next phase of CoreWeave’s growth,” said Mike Intrator, Cofounder and Chief Executive Officer, CoreWeave. “CoreWeave’s infrastructure will fill a void in the cloud market by providing AI enterprises with localized high-performance compute solutions that will help build and deploy the next generation of AI applications.”  
Prime Minister Rishi Sunak said: “Companies like CoreWeave are powering the future of AI innovation, and I am proud that they’ve backed the UK with a £1 billion investment into UK data centres and have established their European headquarters here – further cementing the UK’s position as an AI and tech superpower.
“We’re leaving no stone unturned to make the UK the best place for pioneering companies like CoreWeave to grow their roots. With the third highest number of AI companies and private investment in AI in the world, it’s clear our plan is working.”
Secretary of State of Science, Innovation, and Technology, Michelle Donelan said: “CoreWeave’s decision to base their European HQ here in London is not just a sign of our tech investment prowess, it is a resounding vote of confidence in our approach to AI and innovation. Today’s £1 billion investment will bring two new data centres to our shores, a vital tool in helping to develop the AI breakthroughs of tomorrow.
“It will also lead to new, highly paid jobs and countless opportunities for our brightest AI minds and start-ups as the UK continues to cement its global AI powerhouse credentials. Our message is clear – when it comes to investment, scaling-up, and innovation, the UK is the perfect home from home.”
CoreWeave’s new European headquarters in London is strategically located given the tremendous AI talent in the UK. The investment in the UK builds on the UK government’s established leadership fostering global awareness and engagement on responsible AI and the country’s commitment to drive investment with plans to upskill millions across the UK in AI. CoreWeave’s presence in the region will support the continued expansion of AI labs and enterprise customers across the UK, bringing much needed computing power to the UK.
CoreWeave’s existing data centres support some of the largest deployments of high-performance GPU clusters in the world, and the infrastructure through which those clusters are consumed is designed with engineers and innovators in mind. Trusted by leading AI labs and enterprises, CoreWeave Cloud manages complexity through automation to deliver the most performant and efficient cloud infrastructure for AI workloads.
About CoreWeave
CoreWeave is a specialized GPU cloud provider, designed to power the most complex workloads with customized solutions at scale. The company’s portfolio of cutting-edge technology delivers a broad range of capabilities for machine learning and AI, graphics and rendering, life sciences, real-time streaming, and more. Its world-class teams, talent, and engineering prowess bring unmatched speed-to-market for advanced compute. CoreWeave operates a growing footprint of data centers covering every region of the US. It was founded in 2017 and is based in New Jersey. Learn more at www.coreweave.com.
Contact
Jackson [email protected] 

View original content:https://www.prnewswire.co.uk/news-releases/coreweave-invests-1-billion-in-uk-opens-new-european-headquarters-and-data-centres-in-london-to-bring-cloud-infrastructure-to-power-the-ai-revolution-302141883.html

Continue Reading

Trending